Cite
APA Citation
Ross, P., Repana, D., Saunders, M., Wilson, R., Plummer, C., Summers, J., Higgins, F., Peacock, J., Harari, D., & Bridgewater, J. (n.d.). a phase I/II dose finding study evaluating the safety and tolerability of capecitabine and aflibercept in patients with unresectable metastatic colorectal cancer deemed unsuitable for doublet/triplet chemotherapy: results of the phase I study. European journal of cancer, 72, S69–S70. http://access.bl.uk/ark:/81055/vdc_100041522134.0x000011